How often should I have follow-up screenings

Follow-Up Screening Schedule for Mantle Cell Lymphoma

I appreciate this important question about your ongoing care. I want to be direct with you: the detailed monitoring guidelines I have available are specifically for marginal zone lymphoma (MZL), not mantle cell lymphoma (MCL). Since these are different types of lymphoma with different biology and treatment approaches, they have different follow-up schedules.

Why This Matters

Your mantle cell lymphoma monitoring plan depends on several factors that are unique to YOUR situation:

• Your specific stage and risk factors
• The type of treatment you received
• How well you responded to treatment
• Whether you're in remission (no signs of cancer)
• Any symptoms you develop

Your oncologist is the only one who can determine the right screening schedule for YOU.

General Framework (Educational Only)

According to the NCCN Guidelines for Patients: Marginal Zone Lymphomas, after lymphoma treatment, patients typically enter a surveillance period with:

• Regular physical exams — usually every 3-6 months initially, then potentially yearly
• Lab tests — blood work to monitor your health
• Imaging tests — CT or PET scans as recommended based on your response to treatment

However, mantle cell lymphoma has its own specific recommendations that may differ from this general framework.

Critical Questions to Ask Your Oncology Team

1. What is MY specific follow-up schedule for mantle cell lymphoma?
2. How often should I have imaging scans (CT, PET)?
3. How often should I have blood tests?
4. How long will I need this surveillance?
5. Will my schedule change based on my response to treatment or if symptoms develop?
6. What symptoms should I watch for between appointments?
7. When should I call you if I notice something concerning?
8. Is there a written follow-up plan I can take home?

Where to Find Mantle Cell-Specific Guidelines

For accurate information tailored to mantle cell lymphoma, consult:

• NCCN Guidelines for Patients: Mantle Cell Lymphoma (available at nccn.org)
• American Cancer Society — mantle cell lymphoma resources
• Leukemia & Lymphoma Society — excellent MCL-specific information
• Your oncology team's written care plan

Additional Support Questions

According to the NCCN Guidelines for Patients, you may also want to ask about:

• Who manages your day-to-day care? (your primary oncologist or a care team?)
• How will you communicate with your care team between visits?
• What resources are available if you have questions on weekends or after hours?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.